$18.64
At close: Dec 30, 4:09 PM EDT
$18.48
-0.16-0.86%
After Hours: 4:09 PM EDT
Comments
Loading...
Nurix Therapeutics (NRIX) Forecast
NewsEarningsNurix Therapeutics (NRIX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNurix Therapeutics (NASDAQ:NRIX) Stock Quotes, Forecast and News Summary
Nurix Therapeutics Stock (NASDAQ: NRIX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nurix Therapeutics (NRIX) stock?
You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.
Who are Nurix Therapeutics (NRIX) competitors?
Other companies in Nurix Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
What is the forecast, or price target, for Nurix Therapeutics (NRIX) stock?
Nurix Therapeutics has a consensus price target of $30.17.
What is the current price for Nurix Therapeutics (NRIX)?
The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $18.48 last updated December 30, 2024 at 4:09 PM EST.
Does Nurix Therapeutics (NRIX) pay a dividend?
There are no upcoming dividends for Nurix Therapeutics.
When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?
Nurix Therapeutics’s Q4 earnings are confirmed for Thursday, February 13, 2025.
Is Nurix Therapeutics (NRIX) going to split?
There is no upcoming split for Nurix Therapeutics.
What sector and industry does Nurix Therapeutics (NRIX) operate in?
Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.